Radiation Oncology

ASCO 2025

Questions discussed in this category

What are your top takeaways from ASCO GU 2025?

6 Answers available

Papers discussed in this category

The Lancet. Oncology, 2025 Feb 13

Overall survival and quality of life with [Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Sep 21

Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).

Annals of oncology : official journal of the European Society for Medical Oncology, 2025 Feb 07

Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial.

Related Topics in Radiation Oncology